Natus Medical reported Q4 revenue of $107.7 million, an increase of 7.7% compared to $100.0 million last year. This just beat the $107.6 million Capital IQ estimate. EPS were $0.51, in-line with last year. Analysts polled by Capital IQ were expecting EPS of $0.53.
The company says it sees Q1 revenue of $122.0 million to $124.0 million. The Street is at $116.1 million. EPS is seen at $0.32 to $0.34, as compared to the analyst consensus of $0.36.
For the full year 2017, the company is guiding for revenue of $505.0 million to $510.0 million. The Street is at $480.1 million. Full-year EPS is seen at $1.80 to $1.85. The Street is at $1.86.